Exos TFP Holdings’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Exos TFP Holdings’s Portfolio IBER.WS Stock Details IBER.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-70,500	Closed	-$1.25K	–	572
2022 Q4	$1.25K	Buy	70,500 +63,600	+922%	+$2K	﹤0.01%	487
2022 Q3	$1K	Buy	+6,900	New	+$738	﹤0.01%	468

Other funds holding IBER.WS

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

Exos TFP Holdings's IBER.WS Position: Q1 2023 in Review

Exos TFP Holdings sold out of Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share (IBER.WS) in Q1 2023, closing a stake of 70,500 shares — an estimated $1.25K sold.

Exos TFP Holdings first reported a position in IBER.WS in Q3 2022 and held it in 2 quarters. The position peaked at $1.25K in Q4 2022. 1 fund tracked by Wall St. Rank holds IBER.WS as of Q1 2023.

Exos TFP Holdings reported no remaining Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
Exos TFP Holdings sold 70,500 Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share shares in Q1 2023, an estimated $1.25K.
Exos TFP Holdings first reported a position in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in Q3 2022 and held it in 2 quarters.
Exos TFP Holdings's Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share position peaked at $1.25K in Q4 2022.
1 fund tracked by Wall St. Rank held Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share as of Q1 2023.

Based on Exos TFP Holdings's 13F filing for Q1 2023, filed 10 May 2023.